e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Airway diseases: from invasive to noninvasive biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled MMP-9 in lung cancer
G.E. Carpagnano, D. Lacedonia, E. Costantino, A.R. Depalo, C. Ruggeri, G.P. Palladino, M.P. Foschino Barbaro (Foggia, Italy)
Source:
Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers
Session:
Airway diseases: from invasive to noninvasive biomarkers
Session type:
Poster Discussion
Number:
310
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G.E. Carpagnano, D. Lacedonia, E. Costantino, A.R. Depalo, C. Ruggeri, G.P. Palladino, M.P. Foschino Barbaro (Foggia, Italy). Exhaled MMP-9 in lung cancer. Eur Respir J 2012; 40: Suppl. 56, 310
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Dermcidin identification from exhaled air for lung cancer diagnosis
Source: Eur Respir J 2010; 35: 1182-1185
Year: 2010
Exhaled aldehydes as markers of disease in lung cancer patients
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009
Protein markers in the exhaled breath condensate of lung carcinoma patients
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012
Can exhaled nitric oxide (FeNO) predict radiotherapy-induced lung toxicity in lung cancer patients?
Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Year: 2011
Exhaled biomarkers in lung cancer
Source: Eur Respir J 2009; 34: 261-275
Year: 2009
Detection of p53 mutation in exhaled breath condensate from patients with nonsmall cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 14s
Year: 2002
Tumor size and inflammatory cytokines in exhaled breath condensate in patients with non small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
Pretreatment levels of VEGF and 8-isoprostane in exhaled breath condensate (EBC) and serum of lung cancer patients
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008
Cytokine pattern in the exhaled breath of patients with planocellular lung carcinomas
Source: Annual Congress 2008 - Airway cell biology and immunology
Year: 2008
HPV in exhaled breath condensate of lung cancer patients
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Pretreatment levels of TNF-α in serum and exhaled breath condensate in patients with lung cancer
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007
Neutrophilic airways inflammation in lung cancer: The role of exhaled LTB-4 and IL-8
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
The impact of lung cancer subtypes, smoking status and corticosteroid treatment on exhaled nitric oxide levels in patients with lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Increased levels of fractional exhaled nitric oxide after chemotherapy for lung cancer. Ongoing study
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
Exhaled nitric oxide (eNO) and lung transplantation (LTx): impact of the native lung?
Source: Eur Respir J 2001; 18: Suppl. 33, 179s
Year: 2001
Vascular endothelial growth factor (VEGF) in serum and exhaled breath condensate (EBC) of subjects with non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2007; 30: Suppl. 51, 205s
Year: 2007
Exhaled nitric oxide after lung transplantation: impact of the native lung
Source: Eur Respir J 2003; 21: 429-432
Year: 2003
Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 317s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept